secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2026-03-16T23:59:59+00:00
Accession:  0001628280-26-018163
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen files new corporate presentation; no material updates disclosed
------------------------------------------------------------------------

- Filed 8-K to announce use of updated corporate presentation dated March 2026.
- Presentation covers pipeline and strategy but no specific financial or clinical data provided.
- No earnings, guidance, or operational milestones were released in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026018163/0001628280-26-018163-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000162828026018163/vtgn-20260316.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-018163

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer